Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BioremBIRMF 87 5-Year ROIIC % is 104.86 as of Dec. 2025. GuruFocus rates BIRMF with a GF Score™ of 87/100 and a GF Value™ of $1.94 (Modestly Overvalued). Among 2,782 Industrial Products companies, Biorem ranks better than 95.43% on this metric.
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
Biorem's 5-Year ROIIC % for the quarter that ended in Dec. 2025 was 104.86%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Biorem's 5-Year ROIIC % or its related term are showing as below:
BIRMF's 5-Year ROIIC % is ranked better than 95.43% of 2782
companies
in the Industrial Products industry
Industry Median: 4.55
vs BIRMF: 104.86
Biorem (OTCPK:BIRMF) 5-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Biorem 5-Year ROIIC % Related Terms
Biorem 5-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Biorem's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BIRMF vs VLTO, ZWS, CECO: 5-Year ROIIC % Comparison
For the Pollution & Treatment Controls subindustry, Biorem's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biorem 5-Year ROIIC % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Biorem's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Biorem's 5-Year ROIIC % falls into.
Biorem's 5-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
5-Year ROIIC %
=
5-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
5-Year Incremental Invested Capital**
=
( 3.6274026 (Dec. 2025) - 1.5614189 (Dec. 2020) )
/
( 8.277 (Dec. 2025) - 6.678 (Dec. 2020) )
=
2.0659837
/
1.599
=
129.20%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Biorem (BIRMF) has a 5-Year ROIIC % of 104.86 as of Dec. 2025. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Biorem and its competitors. According to the industry distribution chart, Biorem ranks #127 out of 2782 companies in the Industrial Products industry, placing it in the top 4.6%.
Is Biorem's 5-Year ROIIC % too high?
Biorem's current 5-Year ROIIC % is 104.86. The Industrial Products industry median 5-Year ROIIC % is 4.55. Biorem's value of 104.86 is 2204.6% above this industry median. Based on the distribution chart, Biorem ranks #127 out of 2782 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Biorem has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biorem's 5-Year ROIIC % compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, Biorem ranks #127 out of 2782 companies for 5-Year ROIIC %. This places Biorem in the top 5% of its industry — outperforming the majority of peers. The industry median 5-Year ROIIC % is 4.55. Biorem's value of 104.86 is 2204.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for an Industrial Products company?
The median 5-Year ROIIC % among Industrial Products companies is 4.55, based on 2,782 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biorem's current 5-Year ROIIC % of 104.86 is 2204.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Biorem and its competitors. For the Industrial Products industry, the median 5-Year ROIIC % is 4.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biorem's current 5-Year ROIIC % is 104.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biorem stock overvalued right now?
Based on GuruFocus' analysis, Biorem (BIRMF) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.94, compared to a current price of $2.23 — trading 14.9% above its estimated fair value. The current 5-Year ROIIC % is 104.86 and 2204.6% above the Industrial Products industry median of 4.55. Biorem's overall GF Score™ is 87/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For Biorem (BIRMF), the current 5-Year ROIIC % is 104.86 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biorem (BIRMF) Overvalued in 2026?
Based on GuruFocus' analysis, Biorem stock appears to be overvalued.
The current stock price of $2.23 is trading 14.9% above its estimated GF Value™ of $1.94.
GuruFocus considers Biorem to be Modestly Overvalued.
Key valuation signals for BIRMF:
5-Year ROIIC %: 104.86
GF Value™: $1.94 vs. price of $2.23 (14.9% above fair value)
Industry Position: 2204.6% above the Industrial Products median (#127 of 2782)
No single metric tells the full story. See the BIRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biorem Inc is an environmental biotechnology company. It is involved in the manufacturing of a comprehensive line of high efficiency air pollution control systems that are used to eliminate odorous and harmful contaminants. The company's products include Biofilters, Biogas Solutions, Multi-Stage Systems, Biotrickling filters, and services such as Media Sampling and Analysis, Biological processes and testing, Media replacements and Spare parts, and other related services. The company derives revenues from the sale of standard products, construction projects for specialized products, and services for repairs and maintenance. The group has a business presence in Canada, the United States, China and others, of which key revenue is derived from the United States.
87GF Score
Get the complete analysis for BIRMF
5-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BIRMF has been successfully added to your 
